seed
Stage
1
Investors
About
Lime Therapeutics is a biotechnology company that develops lipid-altering therapeutics using an ultrasensitive lipid detection platform called LipidSense to create precision medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders.
Explore Lime Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.